Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal Holdings's other current liabilities for the quarter that ended in Mar. 2026 was 円66,314 Mil.
Medipal Holdings's quarterly other current liabilities
declined
from Sep. 2025 (円65,989 Mil) to Dec. 2025 (円59,209 Mil) but then
increased
from Dec. 2025 (円59,209 Mil) to Mar. 2026 (円66,314 Mil).
Medipal Holdings's annual other current liabilities
declined
from Mar. 2024 (円69,792 Mil) to Mar. 2025 (円63,644 Mil) but then
increased
from Mar. 2025 (円63,644 Mil) to Mar. 2026 (円66,314 Mil).
Medipal Holdings Other Current Liabilities Related Terms
Medipal Holdings Other Current Liabilities Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings Other Current Liabilities Calculation
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of 円66,314 Mil mean?
Medipal Holdings (TSE:7459) has a Other Current Liabilities of 円66,314 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medipal Holdings.
Is Medipal Holdings' Other Current Liabilities too high?
Medipal Holdings' current Other Current Liabilities is 円66,314 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Other Current Liabilities compare to MCK and CAH?
Medipal Holdings' Other Current Liabilities of 円66,314 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Distribution company?
A good Other Current Liabilities depends on the Medical Distribution industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medipal Holdings. Medipal Holdings's current Other Current Liabilities is 円66,314 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,734.57, compared to a current price of 円2,854.00 — trading 4.4% above its estimated fair value. The current Other Current Liabilities is 円66,314 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Other Current Liabilities is 円66,314 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (TSE:7459) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of 円2,854.00 is trading 4.4% above its estimated GF Value™ of 円2,734.57.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for TSE:7459:
Other Current Liabilities: 円66,314 Mil
GF Value™: 円2,734.57 vs. price of 円2,854.00 (4.4% above fair value)
No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score
Get the complete analysis for TSE:7459
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7459 has been successfully added to your 
